| JPM PACIFIC EQUITY I (ACC) USD | RVI ASIA | 7,65% | · | · | 1.621,10% |
| JPM EUROPE STRATEGIC GROWTH I (ACC) EUR | RVI EUROPA CRECIMIENTO | 10,10% | · | · | 1.144,76% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP | BIOTECNOLOGÍA | 9,10% | -12,98% | 108,74% | 583,46% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY D DIS | BIOTECNOLOGÍA | 8,22% | -14,50% | 101,53% | 556,03% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP | BIOTECNOLOGÍA | 8,61% | -14,20% | 103,96% | 553,14% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | BIOTECNOLOGÍA | 9,43% | -17,70% | 98,03% | 472,49% |
| FRANKLIN TECHNOLOGY I (ACC) EUR | TMT | 29,25% | 68,26% | 186,89% | 449,92% |
| MSIF US ADVANTAGE I (USD) | RVI USA | 25,13% | 45,65% | 154,16% | 443,33% |
| JPM US TECHNOLOGY C (ACC) USD | TMT | 34,09% | 68,37% | 187,75% | 431,70% |
| LYXOR NASDAQ-100 UCITS ETF D EUR | RVI USA | 24,54% | 46,76% | 165,22% | 431,18% |
